Maxine Simmons

Director, BioCatalyst

Maxine has over 30 years commercial experience in start-up and expansion stage private company development. Maxine co-founded one of New Zealand’s first biotechnology companies and was awarded a Distinguished New Zealand Biotechnologist Award in recognition for growing a significant biotechnology export business. Subsequently, Maxine established biotechnology consulting company, BioCatalyst which has provided business advisory services to many early-stage biotechnology ventures.

As founding Chief Executive, Maxine ran early-stage healthcare investment fund, Cure Kid Ventures for the child health research charity, Cure Kids. Maxine’s contribution to the growth of the early-stage investment community in NZ was recently acknowledged by the NZ Angel Association with the awarding of their Kohahitanga award.

Appointed by the Prime Minister to the APEC Business Advisory Council (ABAC) in 2013, Maxine championed Women’s economic empowerment across the Asia Pacific region.

Maxine holds a Master of Science (Hons) degree in biological science from the University of Auckland and is a chartered member of the NZ Institute of Directors. She was a founding director of Industry New Zealand (now New Zealand Trade and Enterprise), a director of NZ’s Foundation for Research, Science and Technology, Industrial Research Ltd and Chair of the NZ biotechnology Industry organization, NZBIO.

Maxine was made a Companion of the New Zealand Order of Merit for her services to science, particularly biotechnology in 2017.

Maxine currently serves on the board of a several New Zealand private companies and is a General Partner of Healthtech venture fund, CaraMed Capital.